Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors
Hiroyuki Suzuki(Kurume University), Takuji Torimura(Omuta hospital), Masahito Nakano(Kurume University), Hironori Koga(Kurume University), Naoki Kamachi(Kurume University), Atsutaka Masuda(Kurume University), Takahiro Seki(Karolinska Institutet), Hirohisa Yano(Kurume University), Miwa Sakai(Kurume University), Tomoharu Yoshizumi(Kyushu University), Shigeo Shimose(Kurume University), Tõru Nakamura, Yihai Cao(Karolinska Institutet), Yasuko Imamura(Kurume University), Masamichi Nakayama(Kurume University), Kazutoyo Morita(Kyushu University), Hideki Iwamoto, Ryoko Kuromatsu(Kurume University), Takashi Niizeki(Kurume University), Toshimitsu Tanaka(Kurume University), Yu Noda(Kurume University), Takahiko Sakaue(Kurume University), Tomotake Shirono(Kurume University)
Cited by 23
Related Papers
Angiogenesis modulates adipogenesis and obesity
|Journal of Clinical Investigation|2007|733
Genomic instability in laminopathy-based premature aging
|Nature Medicine|2005|641
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Therapeutic strategies by modulating oxygen stress in cancer and inflammation
|Advanced Drug Delivery Reviews|2009|542